Aarti Drugs Ltd Board of Directors

Home

Insights

Board of Directors

₹ 0.3 Cr

Volume Transacted

(Nov 13, 2024)

6.4 K

Stocks Traded

(Nov 13, 2024)

Last Updated on: Nov 14, 2024

Board of Directors at Aarti Drugs Ltd

Name	Designation

Ankit Paleja	Independent Director
Bhaskar Thorat	Independent Director
Harit Shah	E D & Wholetime Director
Harshit Savla	ED / Joint MD / Promoter
Krishnacharya Akamanchi	Independent Non Exe. Director

Name	Designation
Ankit Paleja	Independent Director
Bhaskar Thorat	Independent Director
Harit Shah	E D & Wholetime Director
Harshit Savla	ED / Joint MD / Promoter
Krishnacharya Akamanchi	Independent Non Exe. Director

Open Demat Account

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

Key Highlights

Prakash M Patil joins the board as CMD & Executive Director, in a new position in 2023. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Rashesh C Gogri joins the board as ED / MD / Promoter, in a new position in 2023. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Harshit M Savla joins the board as ED / Joint MD / Promoter, in a new position in 2023. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Harit P Shah joins the board as E D & Wholetime Director, in a new position in 2023. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Uday M Patil joins the board as WTD & Executive Director, in a new position in 2023. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.

Aarti Drugs Ltd

NSE: AARTIDRUGS

PRICE

Last updated on:

Last Ten Days Market Price

Date	Price (₹)	Day Open (₹)	Day High (₹)	Day Low (₹)

13 Nov 2024	467.2	477	477	463.5
12 Nov 2024	475.55	475.15	486.15	474.6
11 Nov 2024	477.75	490	493	476.2
08 Nov 2024	490.15	490	495.5	487.3
07 Nov 2024	495.5	494.25	502.5	492.6
06 Nov 2024	494.3	490.95	498	489.35
05 Nov 2024	487.95	485	491.2	482.6
04 Nov 2024	483.55	492.5	499.45	481.2
01 Nov 2024	487.6	494	494	485
31 Oct 2024	483.6	486	494.9	476

Date	Price (₹)
13 Nov 2024	467.2
12 Nov 2024	475.55
11 Nov 2024	477.75
08 Nov 2024	490.15
07 Nov 2024	495.5
06 Nov 2024	494.3
05 Nov 2024	487.95
04 Nov 2024	483.55
01 Nov 2024	487.6
31 Oct 2024	483.6

Company Fundamentals for Aarti Drugs Ltd

Market Cap

₹ 4,295 Cr

EPS

₹ 16.6

P/E Ratio (TTM) *

28.2

P/B Ratio (TTM) *

3.4

Day’s High *

477.0

Day’s Low

₹ 463.5

DTE *

0.5

ROE *

11.9

52 Week High

₹ 634.9

52 Week Low

₹ 430.0

ROCE *

12.8

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Market Price Over Time

Monitoring Aarti Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Aarti Drugs Ltd News Hub

Aarti Drugs to conduct board meeting

Aarti Drugs will hold a meeting of the Board of Directors of the Company on 24 October 202...

18 Oct 202410:48

Aarti Drugs gains after arm receives UK MHRA GMP Compliance Certificate

The company said that there are no financial or material impacts as of now. With the GMP c...

04 Oct 202411:09

Aarti Drugs' Maharashtra facility gets 7 observations from USFDA

The API inspection was conducted from 12 September to 20 September 2024. At the conclusion...

21 Sep 202414:05

Aarti Drugs extends buyback offer period

Aarti Drugs announced that the bidding process of buyback offer will remain open on Monday...

16 Sep 202408:52

Aarti Drugs AGM scheduled

Aarti Drugs announced that the Annual General Meeting (AGM) of the company will be held on...

03 Sep 202411:38

Board of Aarti Drugs approves buyback of shares up to Rs 59.85 cr

The Board of Aarti Drugs at its meeting held on 26 August 2024 has approved buyback of up ...

26 Aug 202417:17

Document

Annual Reports

N/A

Credit Ratings

N/A

Concalls

Data not available

Popular Search

Aarti Drugs Ltd share holding pattern

Aarti Drugs Ltd market cap

Aarti Drugs Ltd share price history

Aarti Drugs Ltd isin code

Sun Pharmaceuticals Industries Ltd board of directors

Divis Laboratories Ltd board of directors

Cipla Ltd board of directors

Torrent Pharmaceuticals Ltd board of directors

Dr Reddys Laboratories Ltd board of directors

Mankind Pharma Ltd board of directors

Zydus Lifesciences Ltd board of directors

Lupin Ltd board of directors

Aurobindo Pharma Ltd board of directors

Alkem Laboratories Ltd board of directors

FAQs for Board of Directors of Aarti Drugs Ltd

How are members of Aarti Drugs Ltd Board of Directors selected?

Members of the Aarti Drugs Ltd Board of Directors are typically selected based on their expertise, experience, and alignment with Aarti Drugs Ltd’s strategic goals. Appointments are made by the nomination and remuneration committee and approved by shareholders. However, the selection process does vary from company to company.

Can shareholders interact with the Aarti Drugs Ltd Board of Directors?

Shareholders can interact with the Aarti Drugs Ltd Board of Directors during the Annual General Meeting (AGM) and through formal communications or queries submitted to the company wherein they have the opportunity to ask questions and provide feedback on the business. Please note different companies have different protocols for shareholders who want to meet the Board of Directors.

How often does the Aarti Drugs Ltd Board of Directors meet?

The Aarti Drugs Ltd Board of Directors typically meets quarterly. However, special meetings may be summoned as needed to address urgent matters. The frequency can vary depending on business needs and regulatory requirements to ensure ongoing oversight and strategic guidance for the company. A scheduled meeting among the Board of Directors may vary from company to company.

What are the responsibilities of the Aarti Drugs Ltd Board of Directors?

The Aarti Drugs Ltd Board of Directors is responsible for setting strategic goals, overseeing company performance, ensuring effective governance, and safeguarding shareholder interests. They provide high-level guidance on corporate policies and risk management. Additionally, they appoint and evaluate senior management and ensure compliance with legal and regulatory requirements. Please note the roles and responsibilities of the Board of Directors may be different from company to company.

Who are the current members of the Board of Directors at Aarti Drugs Ltd?

The current Board of Directors at Aarti Drugs Ltd includes Prakash M Patil( CMD & Executive Director) ,Rashesh C Gogri( ED / MD / Promoter) ,Harshit M Savla( ED / Joint MD / Promoter) ,Harit P Shah( E D & Wholetime Director) ,Uday M Patil( WTD & Executive Director) . The full list can be found on Aarti Drugs Ltd’s official website or recent corporate filings.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.

Unlimited trading at just

~~Rs. 399~~

Rs. 199*